COGNITION THERAPEUTICS INC (CGTX)

US19243B1026 - Common Stock

1.95  +0.02 (+1.04%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
50.72M43.55M28.60M17.41M17.83M
Research and Development
37.20M30.32M18.57M12.89M14.38M
Selling, General, and Administrative Expenses
13.53M13.23M10.03M4.52M3.45M
Operating Income
-50.72M-43.55M-28.60M-17.41M-17.83M
Interest Income/Expense
-27.00K-30.00K1.32M-1.82M-1.26M
Other Income/Expense
24.96M22.18M15.12M11.52M14.24M
Non Recurring Items
N/A0.00440.00K-130.00K0.00
Income Before Taxes
-25.79M-21.40M-11.72M-7.84M-4.84M
Net Income
-25.79M-21.40M-16.25M-12.07M-8.76M
EBITDA
-50.63M-43.47M-28.51M-17.31M-17.75M
 
Per Share Data
EPS Diluted Total Ops
-0.86-0.91-0.72-0.58-0.42
Non GAAP EPS
-0.86-0.91N/AN/AN/A
 
Statistics

All data in USD

Charts